Skip to main content
main-content

The independent medical news service

12-05-2021 | Oncology | News | Article

COVID-19 leaves large cancer screening deficit in USA

Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.

13-04-2021 | Oncology | News | Article

Mechanisms of resistance to KRAS G12C inhibition characterized

US researchers have identified diverse molecular and histologic mechanisms of acquired resistance to KRAS G12C inhibitors in people with cancer.

31-03-2021 | Oncology | News | Article

Worse cancer outcomes in areas of deprivation transcend access to quality care

Researchers have identified an association between socioeconomic deprivation and poor survival in people with cancer participating in clinical trials.

14-01-2021 | Oncology | News | Article

Real-world data support efficacy of SABR for extracranial oligometastases

The beneficial survival outcomes and low toxicity associated with stereotactic ablative body radiotherapy in patients with extracranial oligometastases persist in the real-world setting.

26-11-2020 | Oncology | News | Article

Oligometastatic cancer outcomes acceptable with SABR

Stereotactic ablative radiotherapy is associated with “clinically acceptable” rates of toxicity, local control, progression-free survival, and overall survival in people with oligometastatic cancer, meta-analysis data suggest.

12-03-2020 | Oncology | News | Article

Metastases progression linked to deteriorating HRQoL

Disease progression among patients with metastatic lung, pancreatic, colorectal, and breast cancer is associated with statistically significant and clinically relevant reductions in health-related quality of life, real-world study data show.

Image Credits